Center Laboratories, Inc. (TPEX:4123)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.05
-0.90 (-2.37%)
Aug 11, 2025, 1:30 PM CST
-2.37%
Market Cap27.03B
Revenue (ttm)1.63B
Net Income (ttm)-13.57M
Shares Out712.26M
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividend0.75 (1.98%)
Ex-Dividend DateAug 2, 2024
Volume972,553
Average Volume466,640
Open37.80
Previous Close37.95
Day's Range37.00 - 37.80
52-Week Range30.60 - 52.00
Beta0.42
RSI51.50
Earnings DateAug 12, 2025

About United States Steel

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depressi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

In 2024, Center Laboratories's revenue was 1.62 billion, an increase of 16.06% compared to the previous year's 1.39 billion. Losses were -1.10 billion, 10.9% more than in 2023.

Financial Statements

News

There is no news available yet.